PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Elevating Care in Multiple Myeloma: Translating the Latest Evidence to Clinical Practice in Canada
Visit https://www.peervoice.com/REZ860 to view the entire programme with slides. After completing “Elevating Care in Multiple Myeloma: Translating the Latest Evidence to Clinical Practice in Canada”, participants will be able to: Discuss the latest evidence with new regimens for relapsed/refractory multiple myeloma (MM); Explain what the latest data mean for management of patients with relapsed/refractory MM in Canada; and Evaluate the role of alternate administration formulations and dosing schedules in reducing treatment burden for patients with relapsed/refractory MM.